| Literature DB >> 25427765 |
Ebru Diler, Martin Schicht, Andrea Rabung, Thomas Tschernig1, Carola Meier, Felix Rausch, Fabian Garreis, Lars Bräuer, Friedrich Paulsen.
Abstract
BACKGROUND: Surfactant proteins (SP) secreted by alveolar type 2 cells, play an essential role in maintaining the air-liquid barrier of the lung and are also involved in the opsonisation and clearance of bacteria by phagocytes. We have recently described a novel surfactant protein, SP-H (SFTA3). Expression of SP-H was earlier demonstrated to be upregulated by LPS and negatively regulated by IL-1β and IL-23 in vitro. The influence of SP-H on phagocytosis was measured using a murine and a human phagocytic cell line and fluorescent latex beads.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25427765 PMCID: PMC4256058 DOI: 10.1186/1756-0500-7-851
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Figure 1The phagocytosis efficiency of the alveolar macrophage cell line MH-S and the differentiated lymphoma cell line U937 as a function of SP-H. The phagocytosis efficiency was determined by flow cytometry.
Figure 2The phagocytosis efficiency of the alveolar macrophage cell line MH-S and the differentiated lymphoma cell line U937 as a function of SP-H after incubation in a mixture of three phagocytosis inhibitors: cytochalasin D, nocodazole, and staurosporine. Ns: not significant. The phagocytosis efficiency was determined by flow cytometry.
Figure 3Comparison of phagocytosis efficiencies in absence and presence of phagocytosis inhibitors cytochalasin D, nocodazole and staurosporine. The data shows that treatment of the cells with a mixture of the inhibitors reduces phagocytosis efficiency significantly.